GT Biopharma (GTBP) Short Interest
Nasdaq • GTBP • US36254L4077
As of Oct 28, 2026, ORTEX estimated 17.5% of free float sold short, 4.5 days to cover, cost to borrow 309.88%. Sign up for live short interest data.
Nasdaq • GTBP • US36254L4077
As of Oct 28, 2026, ORTEX estimated 17.5% of free float sold short, 4.5 days to cover, cost to borrow 309.88%. Sign up for live short interest data.
This page tracks how heavily GT Biopharma (Nasdaq:GTBP) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
GT Biopharma (Nasdaq: GTBP) has a market capitalization of $7.11M. Last close $3.95 (as of 2026-11-12); 52-week range $3.86 to $28.75. ORTEX data as of 2026-10-28: short interest was 17.45% of free float, 4.5 days to cover and the average cost to borrow was 309.88%. Sign up for live short interest data.